최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of controlled release : official journal of the Controlled Release Society, v.329, 2021년, pp.847 - 857
Kim, Heegon (Corresponding author.) , Han, Hyeonjeong , Jeong, Moonkyoung , Han, Junhee , Park, Ji-Ho
Abstract Management of lymph node metastasis (LNM) by conventional modalities such as radiotherapy and systemic chemotherapy exhibit limited LNM selectivity and therefore can cause off-target adverse events. While development of LNM-specific drug delivery systems has tremendous potential to provide...
Nat. Rev. Cancer Mehlen 6 449 2006 10.1038/nrc1886 Metastasis: a question of life or death
Curr. Opin. Immunol. Farnsworth 53 64 2018 10.1016/j.coi.2018.04.008 The evolving role of lymphatics in cancer metastasis
Science Brown 359 1408 2018 10.1126/science.aal3662 Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
Science Pereira 359 1403 2018 10.1126/science.aal3622 Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice
Int. J. Gynecol. Cancer Zaal 24 303 2014 10.1097/IGC.0000000000000043 Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study
New Engl J Med Faries 376 2211 2017 10.1056/NEJMoa1613210 Completion dissection or observation for sentinel-node metastasis in melanoma
Acta Obstet Gyn Scan Kenter 79 72 2000 10.1034/j.1600-0412.2000.079001072.x The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma
Lancet Oncology Galimberti 19 1385 2018 10.1016/S1470-2045(18)30380-2 Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
Orv. Hetil. Savolt 154 1934 2013 10.1556/OH.2013.29765 Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial
Lancet Oncol. Donker 15 1303 2014 10.1016/S1470-2045(14)70460-7 Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Am. J. Surg. Kuerer 176 502 1998 10.1016/S0002-9610(98)00253-0 Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer
J. Clin. Oncol. McLaughlin 26 5213 2008 10.1200/JCO.2008.16.3725 Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements
Surg. Oncol. Sakorafas 15 153 2006 10.1016/j.suronc.2006.11.003 Lymphedema following axillary lymph node dissection for breast cancer
Lancet Oncol. Darby 6 557 2005 10.1016/S1470-2045(05)70251-5 Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries
Int J Radiat Oncol Biol Phys Tsoutsou 66 1281 2006 10.1016/j.ijrobp.2006.08.058 Radiation pneumonitis and fibrosis: Mechanisms underlying its pathogenesis and implications for future research: In regard to Tsoutsou and Koukourkis
Brit J Cancer Henson 108 179 2013 10.1038/bjc.2012.575 Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer
New Engl J Med Darby 368 987 2013 10.1056/NEJMoa1209825 Risk of ischemic heart disease in women after radiotherapy for breast cancer
Cancer Biol Med Zhang 11 247 2014 Recent advances in lymphatic targeted drug delivery system for tumor metastasis
N. Engl. J. Med. Berry 353 2005 1784 Effect of screening and adjuvant therapy on mortality from breast cancer
Nat Rev Mater Schudel 4 415 2019 10.1038/s41578-019-0110-7 Material design for lymph node drug delivery
Sci Transl Med Jones 9 2017 10.1126/scitranslmed.aaf9166 Subcutaneous drug delivery: An evolving enterprise
J. Pharm. Pharmacol. Loftsson 62 1607 2010 10.1111/j.2042-7158.2010.01030.x Pharmaceutical applications of cyclodextrins: basic science and product development
Biochim Biophys Acta Rev Cancer Gala 2020 188319 1873 Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Sci. Rep. Zhang 6 36957 2016 10.1038/srep36957 A simple method to improve the stability of docetaxel micelles
Nat Biomed Eng Lu 2 318 2018 10.1038/s41551-018-0234-x Micelles with ultralow critical micelle concentration as carriers for drug delivery
N. Engl. J. Med. Punglia 356 2399 2007 10.1056/NEJMra065241 Local therapy and survival in breast cancer
Front Oncol Jones 8 2018 10.3389/fonc.2018.00036 Growth and immune evasion of Lymph node Metastasis
Science Lee 363 644 2019 10.1126/science.aav0173 Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation
Dis. Model. Mech. Gomez-Cuadrado 10 1061 2017 10.1242/dmm.030403 Mouse models of metastasis: progress and prospects
Bmc Cancer Liao 12 2012 10.1186/1471-2407-12-236 Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities
Tissue Eng Part B Rev Burdett 16 351 2010 10.1089/ten.teb.2009.0676 Engineering tumors: a tissue engineering perspective in cancer biology
Tissue Eng Part C Methods Nii 25 711 2019 10.1089/ten.tec.2019.0189 A Cancer invasion model combined with cancer-associated fibroblasts aggregates incorporating gelatin hydrogel microspheres containing a p53 inhibitor
Acta Biomater. Liu 91 195 2019 10.1016/j.actbio.2019.04.053 AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model
Cancer Investig. Gabizon 19 424 2001 10.1081/CNV-100103136 Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy
Adv. Drug Deliv. Rev. Swartz 50 3 2001 10.1016/S0169-409X(01)00150-8 The physiology of the lymphatic system
J. Mol. Recognit. Torchilin 9 335 1996 10.1002/(SICI)1099-1352(199634/12)9:5/6<335::AID-JMR309>3.0.CO;2-0 Affinity liposomes in vivo: factors influencing target accumulation
Arab. J. Chem. Khan 12 908 2019 10.1016/j.arabjc.2017.05.011 Nanoparticles: properties, applications and toxicities
J. Clin. Oncol. Fisher 15 2483 1997 10.1200/JCO.1997.15.7.2483 Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18
J. Clin. Oncol. Bear 24 2019 2006 10.1200/JCO.2005.04.1665 Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27
JAMA Boughey 310 1455 2013 10.1001/jama.2013.278932 O. Alliance for Clinical Trials in, Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.